Pfizer said preliminary studies suggests that 3 doses of the Pfizer-BioNTech vaccine neutralise the Omicron variant. According to Pfizer data indicate that a third dose increases the neutralisation efficacity by 25-fold compared to the two doses against the Omicron variant. The World Health Organization said it’s still difficult to know the exact impact of the omicron variant and concludes its too early to draw conclusions.